patientsâÂ?Â? point of care in the coming years. However, the disruption of how cancer is managed is not straightforward. Although core diagnostics technologies, which have been tested established ... dissimilar and so…
well known that many factors other than chemotherapy take part in the development of these cancer- related cognitive impairments (CRCI), such as cancer-related fatigue, psychological as well as molecular ... available…
view of funding crunch and inadequate manpower in cytology in developing countries like India, single lifetime screening for cervical cancer has been suggested. In this study, an attempt was made ... most economical…
Treatments are often too toxic to normal cells and they fail to selectively kill cancer stem cells (CSCs), which can survive treatment and, like the queen bee of a beehive ... target CSCs must be developed. Here we…
many decades, early and late stage drug development of anti-cancer drugs have been very much based on tumor sizes evolution. They registration was mostly based on survival increase, although ... immunosuppressive agents…
present review I have mentioned recent statistics of cancer and mentioned few recent developments in cancer research especially on the most common cancers like lung cancer, breast cancer, prostate cancer
genetic aberrations, especially those of cancer causing genes, has offered hopes to treat specific cancers by a variety of strategies. Although gene therapy to infuse correct genes which are devoid ... immunotherapy to…
They can reintroduce missing or depressed genes or gene products, or factors to rewire cancer cells to self-destruct or attract mechanisms that can destroy them. Since 2011, ZIOPHARM Oncology ... build DNA-based…
been a dramatic increase in the rates of occurrence of some cancers, particularly in the more developed countries. Although many therapeutic strategies to prevent and/or cure this disease have ... objective of this…
have developed a high throughput epitope cloning strategy that has identified biomarkers for the early detection of ovarian cancer. We reasoned that appearance of autoantibody biomarkers was more likely ... leading to…
sequencing technology, targeted therapy has been developed by affecting targeted molecules in the signaling pathways. It could act as an alternative strategy of cancer therapeutics. In this way, cancer patients…
transcription factors. ETS factors are common sites of chromosome translocation in cancer and are essential for normal development. Most ETS factors are conserved in mice and their function has been ... rerio, which has…
homeodomain-containing transcription factors that determine cellular identity during development and which are subsequently re-expressed in many types of cancer. Some recent studies have shown ... that HOX genes may…
idiotype (anti-id) Mabs against RP215 were generated and characterized for future development of epitope-specific anti-cancer vaccines in humans. Results: Following successful immunization of rats with ... image of…
which platinumcontaining therapy was able to continue in a patient with metastatic pancreatic cancer following a hypersensitivity reaction to oxaliplatin, by switching to cisplatin after a negative intradermal skin test…
phenomenon of epithelial-mesenchymal transition (EMT) has gained attention in the field of cancer biology for its potential contribution to the progression of carcinomas. Tumor EMT is a phenotypic switch ... involved in…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.